Pradžia › Širdies nepakankamumas › Masčusetsas
Širdies nepakankamumas klinikiniai tyrimai Masčusetsas
45 tyrimai dėl Širdies nepakankamumas ieško dalyvių vietose Masčusetsas.
Miestai Masčusetsas
Oficialus tyrimo tekstas (anglų kalba)
ELEVATE-HFpEF Clinical Study
- Tufts Medical Center, Boston
Renkami dalyviai
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06678841Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Boston
- Research Site, Worcester
Renkami dalyviai3 fazė
Amžius nuo 18 iki 130 · Visoms lytims · Atnaujinta 2026-10-02 · NCT06307652A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Boston Medical Center, Boston
Renkami dalyviai
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-10-01 · NCT07214376Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
- Mass General Brigham, Boston
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 30 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT06517186HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets
- Mass General Brigham, Boston
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 30 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT05873634A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Boston
- Research Site, Boston
- Research Site, New Bedford
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Tufts Medical Center, Boston
Renkami dalyviai3 fazė
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06736574Alleviant ALLAY-HFrEF Study
- Tufts Medical Center, Boston
- Brigham and Women's Hospital, Boston
- Boston Medical Center, Boston
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT06812533Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Boston
- Research Site, Roslindale
Renkami dalyviai3 fazė
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-15 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Boston, MA Investigative Stie 10087, Boston
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-10 · NCT06008197Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- Tufts Medical Center, Boston
- Massachusetts General Hospital, Boston
Renkami dalyviai
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2026-09-09 · NCT06310031Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
- Southcoast Physicians Group, Fall River
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-04 · NCT07069738Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
- Massachusetts General Hospital, Boston
Renkami dalyviai
Amžius 65 ir vyresni · Visoms lytims · Atnaujinta 2026-09-01 · NCT05577819Targeted Artificial Intelligence Language mOdel Recommendations for Heart Failure (TAILOR-HF)
- Mass General Brigham, Boston
Renkami dalyviai
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-08-31 · NCT07337577Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure
- Massachusetts General Hospital, Boston
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-31 · NCT03480633Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Boston Children's Hospital ( Site 0035), Boston
Renkami dalyviai2/3 fazė
29 Days – 17 Years · Visoms lytims · Atnaujinta 2026-08-28 · NCT05714085AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
- Massachusetts General Hospital, Boston
Renkami dalyviai2 fazė
Amžius nuo 40 iki 85 · Visoms lytims · Atnaujinta 2026-08-27 · NCT06793371Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM
- Research Site, Boston
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-26 · NCT07690436Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Boston
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-08-20 · NCT00271180A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Harvard (Massachusetts General Hospital), Boston
- Harvard Medical School - Brigham and Women's Hospital (BWH), Boston
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-19 · NCT05489705LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
- Tenax Investigational Site, Boston
Renkami dalyviai3 fazė
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-08-19 · NCT07288398Alleviant ALLAY-HF Study
- Brigham and Women's Hospital, Boston
- Boston Medical Center, Boston
Renkami dalyviai
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-08-14 · NCT05685303OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
- Tufts Medical Center, Boston
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-08-11 · NCT06939751Assessment of CCM in HF With Higher Ejection Fraction
- Massachusetts General Hospital, Boston
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-06 · NCT05064709Care Transitions App for Patients With Multiple Chronic Conditions
- Brigham and Women's Hospital, Boston
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-07-09 · NCT06051058The STOP-MED CTRCD Trial
- Brigham and Women's Hospital, Boston
Renkami dalyviai4 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-07 · NCT06183437A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Boston Children's Hospital - Main Campus - Cardiology, Boston
Renkami dalyviai3 fazė
Iki 18 metų · Visoms lytims · Atnaujinta 2026-06-29 · NCT07192952PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- Tufts Medical Center, Boston
- Boston Medical Center Corporation, Boston
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-29 · NCT05934487A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Boston Children's Hospital - Main Campus - Cardiology, Boston
Renkami dalyviai3 fazė
6 Months – 17 Years · Visoms lytims · Atnaujinta 2026-06-15 · NCT07188805Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Massachusetts General Hospital, Boston
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-10 · NCT06526195CCM OPEN HF Registry
- Massachusetts General Hospital, Boston
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-23 · NCT07112924Promoting Well-being and Health in Heart Failure
- Massachusetts General Hospital, Boston
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-14 · NCT04829617The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- St Elizabeth's Medical Center, Boston
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess, Boston
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-13 · NCT03142152Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- Joslin Diabetes Center, Boston
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-03-24 · NCT06217302Home Hospital for Suddenly Ill Adults
- Brigham and Women's Hospital, Boston
- Brigham and Women's Faulkner Hospital, Boston
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-17 · NCT03524222Diffusion MRI in Heart Failure
- Massachusetts General Hospital, Charlestown
Renkami dalyviaiAnkstyvoji 1 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2025-12-24 · NCT02973633A SkeleTal Muscle Recovery Intervention With Dietary Protein in Heart Failure
- Tufts Medical Center, Boston
Renkami dalyviai
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2025-11-25 · NCT05627440Pulmonary Artery Catheter in Cardiogenic Shock Trial
- Tufts Medical Center, Boston
Renkami dalyviai
Amžius nuo 18 iki 90 · Visoms lytims · Atnaujinta 2025-10-29 · NCT05485376US Benchmarking Clinical Study
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
- Boston Medical Center, Boston
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2025-10-20 · NCT07215715Left vs Left Randomized Clinical Trial
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-10-02 · NCT05650658Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.